SHR1701

Clinical trials for SHR1701 explained in plain language.

Never miss a new study

Get alerted when new SHR1701 trials appear

Sign up with your email to follow new studies for SHR1701, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cocktail of drugs aims to boost stomach cancer treatment

Disease control Recruiting now

This Phase 2 trial tests whether adding an extra drug (either SHR2554 or apatinib) to standard immunotherapy plus chemotherapy can help people with advanced gastric cancer who don't get enough benefit from current treatments. About 78 adults with stage III or IV stomach cancer wi…

Matched conditions: SHR1701

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC

SHR1701

Get alerted when new SHR1701 trials appear

New cocktail of drugs aims to boost stomach cancer treatment